Riskpilot← Back to searchSign inGet full accessBROTAN HOLDING AS
ASActiveOrg 918790055Edvard Griegs vei 29, 4023 StavangerMedical specialists activities · NACE 8622Est. 20170 employees
Revenue 2025
NOK 0
EBITDA margin
—
+11% vs 2024
Equity ratio
65.3%
Financial strength
Net profit 2025
NOK 3,9M
-9% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -35K | +11% |
| Net profit | NOK 3,9M | -9% |
| Total assets | NOK 12,1M | +20% |
| Equity | NOK 7,9M | -3% |
| Employees | 0 | — |
Legal name
BROTAN HOLDING AS
Org number
918790055
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
5. april 2017
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investering i annen forretningsvirksomhet, eiendom og verdipapirer og annet som naturlig faller sammen med dette. Herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Edvard Griegs vei 29, 4023 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −26 | −40 | −33 | −39 | −35 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −26 | −40 | −33 | −39 | −35 |
| Net financials | 1 950 | 1 525 | 2 887 | 4 279 | 3 890 |
| Profit before tax | 1 924 | 1 485 | 2 854 | 4 240 | 3 856 |
| Tax | −0 | 2 | 4 | 2 | 3 |
| Net profit | 1 924 | 1 483 | 2 850 | 4 238 | 3 853 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 365 | 4 194 | 6 890 | 10 153 | 12 145 |
| Equity | 3 009 | 3 592 | 5 442 | 8 180 | 7 932 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 356 | 602 | 1 448 | 1 973 | 4 212 |
| Total debt | 1 356 | 602 | 1 448 | 1 973 | 4 212 |
EBITDA margin
-3491400.0%
This company
15.8%
Market median
-22097568% vs market
20212025
Equity ratio
65.3%
This company
38.2%
Market median
+71% vs market
20212025
Return on equity
48.6%
This company
18.4%
Market median
+164% vs market
20212025
Net profit margin
385263400.0%
This company
8.1%
Market median
+4756338172% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BROTAN HOLDING AS 
Hjertespesialist Torstein Valborgland AsBoard members of BROTAN HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Torstein Valborgland | Chairman | 0 companies |